UK medical cannabis registry: assessment of clinical outcomes in patients with headache disorders.

Martha NicholasSimon ErridgeLara BapirManaswini PillaiNishaanth DalavayeCarl HolveyRoss CoomberJames J RuckerMark W WeatherallMikael Hans Sodergren

Published in: Expert review of neurotherapeutics (2023)

Improvements in headache/migraine-specific PROMs and general health-related quality of life were associated with the initiation of CBMPs in patients with headache disorders. Cautious interpretation of results is necessary, and randomized control trials are required to ascertain causality.

Keyphrases

patient reported outcomes
healthcare
double blind
open label
phase iii
placebo controlled
cross sectional
emergency department
adverse drug
drug induced